- Home
- IDYA vs GRND Comparison
IDYA vs GRND Comparison
Compare IDYA & GRND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDYA | GRND |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IDYA | GRND |
|---|---|---|
| Price | $34.38 | $13.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $49.18 | $22.75 |
| AVG Volume (30 Days) | 943.7K | ★ 1.2M |
| Earning Date | 02-12-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $214,834,000.00 | ★ $411,545,000.00 |
| Revenue This Year | $2,662.86 | $29.03 |
| Revenue Next Year | N/A | $21.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5377.66 | 28.97 |
| 52 Week Low | $13.45 | $11.73 |
| 52 Week High | $37.08 | $25.13 |
Technical Indicators
Market Signals| Indicator | IDYA | GRND |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 47.52 |
| Support Level | $33.11 | $12.86 |
| Resistance Level | $34.45 | $14.24 |
| Average True Range (ATR) | 1.14 | 0.36 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 44.14 | 42.75 |
Price Performance
Historical ComparisonAbout IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.